Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Curcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro
Hosni Cherif, Daniel G. Bisson, Peter Jarzem, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 4, pp. 433-433
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
LaTonya J. Hickson, Larissa Prata, Shane A. Bobart, et al.
EBioMedicine (2019) Vol. 47, pp. 446-456
Open Access | Times Cited: 972
Strategies for targeting senescent cells in human disease
Nathan Gasek, George A. Kuchel, James L. Kirkland, et al.
Nature Aging (2021) Vol. 1, Iss. 10, pp. 870-879
Open Access | Times Cited: 346
Targeting cellular senescence with senotherapeutics: senolytics and senomorphics
Lei Zhang, Louise E. Pitcher, Vaishali Prahalad, et al.
FEBS Journal (2022) Vol. 290, Iss. 5, pp. 1362-1383
Open Access | Times Cited: 309
Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice
Emanuel J. Novais, Victoria A. Tran, Shira N. Johnston, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 262
Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Tareq Saleh, Sarah Bloukh, Valerie J. Carpenter, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 822-822
Open Access | Times Cited: 227
A Senescence-Centric View of Aging: Implications for Longevity and Disease
Michela Borghesan, Willem M.H. Hoogaars, Marta Varela-Eirín, et al.
Trends in Cell Biology (2020) Vol. 30, Iss. 10, pp. 777-791
Open Access | Times Cited: 205
Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions
Amir Kamali, Reihane Ziadlou, Gernot Lang, et al.
Theranostics (2020) Vol. 11, Iss. 1, pp. 27-47
Open Access | Times Cited: 182
Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases
Sofia M. Lagoumtzi, Niki Chondrogianni
Free Radical Biology and Medicine (2021) Vol. 171, pp. 169-190
Closed Access | Times Cited: 173
Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury
Milad Ashrafizadeh, Zahra Ahmadi, Reza Mohammadinejad, et al.
Current Molecular Medicine (2019) Vol. 20, Iss. 2, pp. 116-133
Closed Access | Times Cited: 164
Senescent Cells: Emerging Targets for Human Aging and Age-Related Diseases
Shuling Song, Eric W.‐F. Lam, Tamar Tchkonia, et al.
Trends in Biochemical Sciences (2020) Vol. 45, Iss. 7, pp. 578-592
Open Access | Times Cited: 155
Senolytic agent Quercetin ameliorates intervertebral disc degeneration via the Nrf2/NF-κB axis
Zewei Shao, Binming Wang, Yinghan Shi, et al.
Osteoarthritis and Cartilage (2020) Vol. 29, Iss. 3, pp. 413-422
Open Access | Times Cited: 144
The Nrf2 antioxidant defense system in intervertebral disc degeneration: Molecular insights
Qian Xiang, Yongzhao Zhao, Jialiang Lin, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 8, pp. 1067-1075
Open Access | Times Cited: 99
Cellular Senescence in Intervertebral Disc Aging and Degeneration: Molecular Mechanisms and Potential Therapeutic Opportunities
Prashanta Silwal, Allison M. Nguyen-Thai, Haneef Ahamed Mohammad, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 686-686
Open Access | Times Cited: 80
Vanillin: A food additive with multiple biological activities
Ahmed Olatunde, Aminu Mohammed, Mohammed Auwal Ibrahim, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 5, pp. 100055-100055
Open Access | Times Cited: 76
Single-Cell RNA-Seq Analysis of Cells from Degenerating and Non-Degenerating Intervertebral Discs from the Same Individual Reveals New Biomarkers for Intervertebral Disc Degeneration
Hosni Cherif, Matthew Mannarino, Alain Pacis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3993-3993
Open Access | Times Cited: 70
Caffeine Modulates Cadmium-Induced Oxidative Stress, Neuroinflammation, and Cognitive Impairments by Regulating Nrf-2/HO-1 In Vivo and In Vitro
Amjad Khan, Muhammad Ikram, Tahir Muhammad, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 5, pp. 680-680
Open Access | Times Cited: 121
Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities
Shuling Song, Tamar Tchkonia, Jing Jiang, et al.
Advanced Science (2020) Vol. 7, Iss. 23
Open Access | Times Cited: 104
Emerging use of senolytics and senomorphics against aging and chronic diseases
Jan Martel, David M. Ojcius, Cheng‐Yeu Wu, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 6, pp. 2114-2131
Closed Access | Times Cited: 99
Senolytics for Cancer Therapy: Is All that Glitters Really Gold?
Valerie J. Carpenter, Tareq Saleh, David A. Gewirtz
Cancers (2021) Vol. 13, Iss. 4, pp. 723-723
Open Access | Times Cited: 90
Senotherapeutic drugs for human intervertebral disc degeneration and low back pain
Hosni Cherif, Daniel G. Bisson, Matthew Mannarino, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 87
Mechanisms of aging and potential role of selected polyphenols in extending healthspan
Gian Luigi Russo, Carmela Spagnuolo, Maria Russo, et al.
Biochemical Pharmacology (2019) Vol. 173, pp. 113719-113719
Closed Access | Times Cited: 86
Relevance of Nrf2 and heme oxygenase-1 in articular diseases
María José Alcaraz, Marı́a Luisa Ferrándiz
Free Radical Biology and Medicine (2019) Vol. 157, pp. 83-93
Closed Access | Times Cited: 77
Recent advances in the discovery of senolytics
Lei Zhang, Louise E. Pitcher, Vaishali Prahalad, et al.
Mechanisms of Ageing and Development (2021) Vol. 200, pp. 111587-111587
Open Access | Times Cited: 69
Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies
Hanxin Liu, Huifang Zhao, Yu Sun
Seminars in Cancer Biology (2021) Vol. 86, pp. 769-781
Open Access | Times Cited: 68
Targeting senescence as an anticancer therapy
Laura Bousset, Jesús Gil
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3855-3880
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top